Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06438250 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

68Ga-JH04 PET/CT: Dosimetry and Biodistribution Studies

StatusRecruiting
PhaseEarly Phase 1
Started2024-03-01
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 14, 2024 (before its estimated May 1, 2025 completion). Its status may not reflect the trial's current state.

Amendment history

2024-11-12
Study Status, Arms and Interventions, Outcome Measures v2
Primary completion date2024-08-01→2025-05-01
Completion date2024-10-01→2025-12-31
Secondary endpointsdetails revised at 2 of 2 entries
2024-07-23
Study Identification, Study Status, Study Description, Study Design, Arms and Interventions, Outcome Measures v1
Primary completion date2024-06-10→2024-08-01
Completion date2024-07-01→2024-10-01
Interventions68Ga-FAPI-JH04 (Drug)→68Ga-JH04 (Drug)
Secondary endpointsdetails revised at 1 of 2 entries
Study description-15 characters
[...] nd showed high efficacy in tumor staging and restaging. 68Ga-FAPI-JH04, a novel radiopharmaceutical targeting FAP, demostrate [...] the safety, biodistribution, and radiation dosimetry of 68Ga-FAPI-JH04 in patients with different types of cancer were observed to evaluate the dosimetric characteristics of 68Ga-FAPI-JH04.
Study title-5 characters
68Ga-FAPI-JH04 PET/CT: Dosimetry and Biodistribution Studies
2024-05-27
Original filing
68Ga-JH04 is a novel radiotracer targeting fibroblast activation protein (FAP). In this study, we observed the safety, biodistribution, and radiation dosimetry of 68Ga-JH04 in patients with different types of cancer.
Trial Details
NCT Number NCT06438250
Lead Sponsor First Affiliated Hospital of Fujian Medical University
Conditions Malignant Neoplasm
Enrollment 5 participants
Start Date 2024-03-01
Primary Completion 2025-05-01 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-11-14